Dementia medicine, particularly in the context of Alzheimer's Disease, focuses on various approaches to manage and treat cognitive decline. Current treatments primarily aim to alleviate symptoms rather than cure the underlying causes. Medications like cholinesterase inhibitors (such as donepezil, rivastigmine, and galantamine) are commonly prescribed to improve cognitive function by enhancing neurotransmitter activity in the brain. Another class of drugs, NMDA receptor antagonists like memantine, helps regulate glutamate activity, which is involved in learning and memory. Beyond pharmacological interventions, holistic approaches include cognitive stimulation therapy, physical exercise, and supportive care to enhance quality of life. Ongoing research aims to develop disease-modifying treatments that target the underlying pathology of Alzheimer's, addressing beta-amyloid plaques and tau tangles, to potentially slow disease progression.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States